Beijing Airdoc Technology Co., Ltd. logo

Beijing Airdoc Technology Co., Ltd. (2251)

Market Closed
13 Aug, 08:00
HKEX HKEX
9. 50
HKD
+0.62
+6.982%
HKD
1.22B Market Cap
- P/E Ratio
- Div Yield
500 Volume
- Eps
8.88 HKD
Previous Close
Add Transaction
Day Range
8.88 9.5
Year Range
8.86 16
Want to track 2251 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

2251 closed today higher at 9.5 HKD, an increase of 6.982% from yesterday's close, completing a monthly decrease of -13.3212% or -1.46 HKD. Over the past 12 months, 2251 stock lost -22.1311%.
2251 is not paying dividends to its shareholders.
The last earnings report, released on Mar 26, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

2251 Chart

People also search for

Global Mastermind Capital Limited
0.11 HKD
0%
Tian Tu Capital Co., Ltd.
2 HKD
0%
Sinohealth Holdings Ltd.
5.1 HKD
+0.5917%
Get Nice Holdings Limited
3.8 HKD
+0.7958%
IntelliCentrics Global Holdings Ltd.
4.06 HKD
-0.2457%

Beijing Airdoc Technology Co., Ltd. (2251) FAQ

What is the stock price today?

The current price is 9.50 HKD.

On which exchange is it traded?

Beijing Airdoc Technology Co., Ltd. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 2251.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.22B.

Has Beijing Airdoc Technology Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Beijing Airdoc Technology Co., Ltd. Profile

Insurance Industry
Financials Sector
Mr. Dalei Zhang CEO
HKEX Exchange
CNE100004QQ9 ISIN
China Country
193 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Beijing Airdoc Technology Co., Ltd. is at the forefront of medical innovation, leveraging artificial intelligence (AI) to transform retina-based early detection, diagnosis, and health risk assessment. Catering to medical institutions, consumer healthcare environments, and eye health management settings, Airdoc's revolutionary solutions extend its reach not only across Mainland China but also to international markets. Founded in 2015, with its headquarters nestled in Beijing, the heart of the People's Republic of China, Airdoc has rapidly emerged as a pioneer in integrating AI technologies to address pressing healthcare challenges.

Products and Services

  • Airdoc-AIFUNDUS (1.0)

    This inaugural AI-empowered product is designed to assist in the auxiliary diagnosis through retina-based analysis, setting the foundation for the company's innovative approach to healthcare solutions.

  • Airdoc-AIFUNDUS (2.0)

    Built upon its predecessor, the 2.0 version enhances the auxiliary diagnosis capabilities to include hypertensive retinopathy, retinal vein occlusion, and age-related macular degeneration, offering broader coverage for eye health issues.

  • Airdoc-AIFUNDUS (3.0)

    Expanding its diagnostic horizon, the Airdoc-AIFUNDUS (3.0) focuses on the auxiliary diagnosis of pathological myopia and retinal detachment, showcasing Airdoc's commitment to evolving healthcare needs.

  • Glaucoma, Cataracts, ICVD and ASCVD, Gestational Diabetic Retinopathy, Gestational Hypertensive Retinopathy, Papilledema Intracranial Hypertension Retinopathy, and Anemia SaMDs

    Airdoc offers a suite of Software as a Medical Device (SaMD) solutions targeting a spectrum of conditions from glaucoma to anemia, each designed to detect and diagnose with precision and efficiency.

  • Health Risk Assessment Solutions

    These solutions are pivotal in detecting risk indicators such as retinal abnormalities, vascular diseases, vitreous abnormalities, and more. Targeting healthcare providers like health checkup centers, insurance companies, and pharmacies, Airdoc facilitates early intervention for a range of conditions including cardiovascular diseases and congenital anomalies of the retina.

  • Hardware Devices

    Complementing its software innovations, Airdoc provides state-of-the-art hardware for comprehensive diagnostic capabilities. The AI-FUNDUSCAMERA series, including the AI-FUNDUSCAMERA-P, -D, and -M models, represents the cutting edge in fundus camera technology, empowering healthcare providers with tools for accurate and reliable eye examinations.

Contact Information

Address: Deputy Building, Building 2
Phone: 86 10 8236 2300